Literature DB >> 30624806

Sepsis erodes CD8+ memory T cell-protective immunity against an EBV homolog in a 2B4-dependent manner.

Jianfeng Xie1, Rebecca L Crepeau1, Ching-Wen Chen1, Wenxiao Zhang1, Shunsuke Otani1, Craig M Coopersmith1,2, Mandy L Ford1,2,3.   

Abstract

Epstein-Barr virus (EBV) reactivation commonly occurs following sepsis, but the mechanisms underlying this are unknown. We utilized a murine EBV homolog (gHV) and the cecal ligation and puncture model of polymicrobial sepsis to study the impact of sepsis on gHV reactivation and CD8+ T cell immune surveillance following a septic insult. We observed a significant increase in the frequency of gHV-infected germinal center B cells on day 7 following sepsis. This increase in viral load was associated with a concomitant significant decrease in the frequencies of gHV-specific CD8+ T cells, as measured by class I MHC tetramers corresponding to the immunodominant viral epitopes. Phenotypic analysis revealed an increased frequency of gHV-specific CD8+ T cells expressing the 2B4 coinhibitory receptor in septic animals compared with sham controls. We sought to interrogate the role of 2B4 in modulating the gHV-specific CD8+ T cell response during sepsis. Results indicated that in the absence of 2B4, gHV-specific CD8+ T cell populations were maintained during sepsis, and gHV viral load was unchanged in 2B4-/- septic animals relative to 2B4-/- sham controls. WT CD8+ T cells upregulated PD-1 during sepsis, whereas 2B4-/- CD8+ T cells did not. Finally, adoptive transfer studies revealed a T cell-intrinsic effect of 2B4 coinhibition on virus-specific CD8+ T cells and gHV viral load during sepsis. These data demonstrate that sepsis-induced immune dysregulation erodes antigen-specific CD8+ responses against a latent viral infection and suggest that blockade of 2B4 may better maintain protective immunity against EBV in the context of sepsis. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  CD8+ T cell; immune memory; sepsis; virus-specific T cell responses

Mesh:

Substances:

Year:  2019        PMID: 30624806      PMCID: PMC7094871          DOI: 10.1002/JLB.4A0718-292R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  52 in total

1.  Latent antigen vaccination in a model gammaherpesvirus infection.

Authors:  E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Severe sepsis and septic shock.

Authors:  Derek C Angus; Tom van der Poll
Journal:  N Engl J Med       Date:  2013-11-21       Impact factor: 91.245

Review 4.  Regulation of Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata
Journal:  Microbiol Immunol       Date:  2014-06       Impact factor: 1.955

5.  Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.

Authors:  Christopher W Seymour; Foster Gesten; Hallie C Prescott; Marcus E Friedrich; Theodore J Iwashyna; Gary S Phillips; Stanley Lemeshow; Tiffany Osborn; Kathleen M Terry; Mitchell M Levy
Journal:  N Engl J Med       Date:  2017-05-21       Impact factor: 91.245

6.  Cutting edge: an NK cell-independent role for Slamf4 in controlling humoral autoimmunity.

Authors:  Daniel R Brown; Silvia Calpe; Marton Keszei; Ninghai Wang; Shannon McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

Review 7.  CMV in critically ill patients: pathogen or bystander?

Authors:  Ajit P Limaye; Michael Boeckh
Journal:  Rev Med Virol       Date:  2010-11       Impact factor: 6.989

8.  Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo.

Authors:  Christopher M Collins; Samuel H Speck
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

9.  Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.

Authors:  Alexandra Heininger; Helene Haeberle; Imma Fischer; Robert Beck; Reimer Riessen; Frank Rohde; Christoph Meisner; Gerhard Jahn; Alfred Koenigsrainer; Klaus Unertl; Klaus Hamprecht
Journal:  Crit Care       Date:  2011-03-01       Impact factor: 9.097

10.  Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.

Authors:  Katherine Chang; Catherine Svabek; Cristina Vazquez-Guillamet; Bryan Sato; David Rasche; Strother Wilson; Paul Robbins; Nancy Ulbrandt; JoAnn Suzich; Jonathan Green; Andriani C Patera; Wade Blair; Subramaniam Krishnan; Richard Hotchkiss
Journal:  Crit Care       Date:  2014-01-04       Impact factor: 9.097

View more
  8 in total

1.  Sepsis-Induced State of Immunoparalysis Is Defined by Diminished CD8 T Cell-Mediated Antitumor Immunity.

Authors:  Derek B Danahy; Samarchith P Kurup; Christina S Winborn; Isaac J Jensen; John T Harty; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

2.  Severity of Sepsis Determines the Degree of Impairment Observed in Circulatory and Tissue-Resident Memory CD8 T Cell Populations.

Authors:  Steven J Moioffer; Derek B Danahy; Stephanie van de Wall; Isaac J Jensen; Frances V Sjaastad; Scott M Anthony; John T Harty; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2021-09-03       Impact factor: 5.426

3.  Identifying Potential Effective Diagnostic and Prognostic Biomarkers in Sepsis by Bioinformatics Analysis and Validation.

Authors:  Xu Huang; Jixiang Tan; Xiaoying Chen; Lin Zhao
Journal:  Int J Gen Med       Date:  2022-07-06

4.  Expression of PD-1 on Memory T Lymphocytes Predicts 28-Day Mortality of Patients with Sepsis: A Prospective Observational Study.

Authors:  Qingxiang Liu; Ming Xue; Qianwen Song; Jianfeng Xie; Yi Yang; Songqiao Liu
Journal:  J Inflamm Res       Date:  2022-09-01

Review 5.  CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State.

Authors:  Matthew D Martin; Vladimir P Badovinac; Thomas S Griffith
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

Review 6.  IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis.

Authors:  Kristen N Morrow; Craig M Coopersmith; Mandy L Ford
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

Review 7.  Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.

Authors:  Margaret A McBride; Tazeen K Patil; Julia K Bohannon; Antonio Hernandez; Edward R Sherwood; Naeem K Patil
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

8.  The IL-27 receptor regulates TIGIT on memory CD4+ T cells during sepsis.

Authors:  Kristen N Morrow; Zhe Liang; Ming Xue; Deena B Chihade; Yini Sun; Ching-Wen Chen; Craig M Coopersmith; Mandy L Ford
Journal:  iScience       Date:  2021-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.